Note: Ingredients listed on restricted chemical lists
EC/CAS
209-136-7/556-67-2
Name of the chemical
D4
Concentration
<1
EC/CAS
208-764-9/541-02-6
Name of the chemical
D5
Concentration
<1
EC/CAS
208-762-8/540-97-6
Name of the chemical
D6
Concentration
<1
General Information
Version
4.0
Revision date
2022-01-07
Product name
MED2-4102
Product Synonyms
Barium Sulfate Masterbatch
Emergency telephone
+1 703-527-3887 CHEMTREC (International and Maritime
Icons in SDS
Company Information
company name
NuSil Technology Europe
e-mail address of the competent person responsible for the Safety Data Sheet
ehs@nusil.com
GHS Information
Signal word
-
Hazard Codes
Hazard statements (CLP)
H411
Hazard statements
Code
Statements
H411
Toxic to aquatic life with long lasting effects
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
Hazard statements
see section 16 : H411 - Toxic to aquatic life with long lasting effects.
2.2 Label elements
Labelling
Hazard pictograms
GHS09
Precautionary statements
P273 - Avoid release to the environment P391 - Collect spillage. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
Other hazards which do not result in classification
Exposure may aggravate pre-existing eye, skin, or respiratory conditions. Component Octamethylcyclotetrasiloxane (556-67-2) This substance meets the PBT criteria of REACH regulation, annex XIII This substance meets the vPvB criteria of REACH regulation, annex XIII Decamethylcyclopentasiloxane (541-02-6) This substance meets the vPvB criteria of REACH regulation, annex XIII Dodecamethylcyclohexasiloxane (540-97-6) This substance meets the vPvB criteria of REACH regulation, annex XIII The substance/mixture does not contain substance(s) equal to or greater than 0.1% by weight that are present in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605
